Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OSCIENT PHARMACEUTICALS CORP | 36,629 | reported | 25 Feb 2008 | tx 8+481,701 |
| Vericel Corp | 36,500 | reported | 24 Feb 2026 | tx 262+5,614,779−1,570,431 |
| Trevi Therapeutics, Inc. | 35,000 | reported | 03 Jun 2026 | tx 8+223,684 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jun 2026 | GRANT_AWARD | Trevi Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 24 Feb 2026 | TAX_WITHHOLDING | Vericel Corp | 8,824 | 38.09 USD | |
| 24 Feb 2026 | EXERCISE | Vericel Corp | 18,250 | — | |
| 24 Feb 2026 | EXERCISE | Vericel Corp | 18,250 | 0.00 USD | |
| 24 Feb 2026 | EXERCISE | Vericel Corp | 18,250 | — | deriv |
| 24 Feb 2026 | EXERCISE | Vericel Corp | 18,250 | — | deriv |
| 18 Feb 2026 | EXERCISE | Vericel Corp | 11,700 | 0.00 USD | |
| 18 Feb 2026 | EXERCISE | Vericel Corp | 18,250 | — | |
| 18 Feb 2026 | TAX_WITHHOLDING | Vericel Corp | 5,657 | 37.41 USD | |
| 19 Feb 2026 | GRANT_AWARD | Vericel Corp | 73,000 | 0.00 USD | deriv |
| 18 Feb 2026 | EXERCISE | Vericel Corp | 18,250 | — | deriv |
| 19 Feb 2026 | GRANT_AWARD | Vericel Corp | 182,500 | 0.00 USD | deriv |
| 18 Feb 2026 | EXERCISE | Vericel Corp | 11,700 | — | deriv |
| 30 Jun 2025 | GRANT_AWARD | Vericel Corp | 123 | 36.17 USD | |
| 11 Jun 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Vericel Corp | 14,063 | 2.65 USD | |
| 14 May 2025 | SALE | Vericel Corp | 14,062 | 42.25 USD | |
| 14 May 2025 | EXERCISE | Vericel Corp | 14,062 | 2.65 USD | |
| 15 May 2025 | SALE | Vericel Corp | 14,063 | 41.53 USD | |
| 14 May 2025 | EXERCISE | Vericel Corp | 14,062 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Vericel Corp | 14,063 | 0.00 USD | deriv |
| 10 Apr 2025 | EXERCISE | Vericel Corp | 24,850 | 2.75 USD | |
| 09 Apr 2025 | SALE | Vericel Corp | 24,850 | 41.11 USD | |
| 09 Apr 2025 | EXERCISE | Vericel Corp | 24,850 | 2.75 USD | |
| 10 Apr 2025 | SALE | Vericel Corp | 24,850 | 41.89 USD |
1 purchase reported after at least 12 months of silence — most recent on 16 Sept 2014.